Roche/Spark Acquisition: First Gene Therapy Deal Clears FTC With No Divestiture

 
• By Brenda Sandburg
WASHINGTON, DC - SEPTEMBER 28, 2013: Federal Trade Commission Building in Washington, DC.
FTC finds no antiturst issues in Roche's proposed acquisition of Spark Therapeutics

More from Cell & Gene Therapies

More from Advanced Technologies